Wedbush Reiterates Outperform Rating for Theseus Pharmaceuticals
THRXDelisted Stock | USD 3.71 0.14 3.92% |
Slightly above 55% of Theseus Pharmaceuticals' investors are presently thinking to get in. The analysis of current outlook of investing in Theseus Pharmaceuticals suggests that some traders are interested regarding Theseus Pharmaceuticals' prospects. Theseus Pharmaceuticals' investing sentiment can be driven by a variety of factors including economic data, Theseus Pharmaceuticals' earnings reports, geopolitical events, and overall market trends.
Theseus |
Theseus Pharmaceuticals s stock had its outperform rating reaffirmed by investment analysts at Wedbush in a research note issued to investors on Thursday, RTT News reports. They presently have a 7.00 price target on the stock. Wedbushs price objective would suggest a potential upside of 114.07 percent from the companys previous close.
Read at thelincolnianonline.com
Theseus Pharmaceuticals Fundamental Analysis
We analyze Theseus Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Theseus Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Theseus Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Price To Book
Price To Book Comparative Analysis
Theseus Pharmaceuticals is currently under evaluation in price to book category among its peers. Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
Theseus Pharmaceuticals Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Theseus Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Theseus Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Theseus Pharmaceuticals by comparing valuation metrics with similar companies.
Peers
Theseus Pharmaceuticals Related Equities
TERN | Terns Pharmaceuticals | 3.41 | ||||
RCUS | Arcus Biosciences | 3.14 | ||||
MRSN | Mersana Therapeutics | 3.04 | ||||
IMRX | Immuneering Corp | 0.95 | ||||
BPMC | Blueprint Medicines | 1.12 | ||||
HOOK | Hookipa Pharma | 1.16 | ||||
DAWN | Day One | 1.81 | ||||
CGEM | Cullinan Oncology | 2.81 | ||||
ELVN | Enliven Therapeutics | 3.36 | ||||
GLUE | Monte Rosa | 3.52 | ||||
DSGN | Design Therapeutics | 4.62 | ||||
PMVP | Pmv Pharmaceuticals | 4.73 | ||||
ERAS | Erasca | 4.95 | ||||
XFOR | X4 Pharmaceuticals | 5.13 | ||||
RLAY | Relay Therapeutics | 6.00 | ||||
IPSC | Century Therapeutics | 7.74 |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Consideration for investing in Theseus Stock
If you are still planning to invest in Theseus Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Theseus Pharmaceuticals' history and understand the potential risks before investing.
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |